Table 2.

Detection of HBV^a Antibodies and HSMBC^b Following Vaccination

	Infection Status	No. of Patients	No. with HBV Ab (%)	p Value	No. of Patients	No. with HSMBC (%)	p Value
Week 28
	HIV+	12	8 (67)	0.14	12	6 (50)	0.09
	HIV−	15	14 (93)		15	13 (87)
Persistence of Responses at Week 72/76 (for those subjects who had positive HBV Ab responses at week 28)
	HIV+	8	7 (88)	1.0	7	5 (71)	0.54
	HIV−	14	13 (93)		10	9 (90)

^aHBV = hepatitis B virus; Ab = Antibodies

^bHSMBC = hepatitis B specific memory B cells